We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

174 hedge funds and large institutions have $1.52B invested in Acorda Therapeutics in 2014 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 58 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 20

60% more call options, than puts

Call options by funds: $13.3M | Put options by funds: $8.31M

7% more funds holding

Funds holding: 162 → 174 (+12)

9% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 58

3% more capital invested

Capital invested by funds: $1.47B → $1.52B (+$46.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
174
Holders Change
+12
Holders Change %
+7.41%
% of All Funds
5.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
63
Reduced
58
Closed
20
Calls
$13.3M
Puts
$8.31M
Net Calls
+$4.95M
Net Calls Change
+$6.72M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$42.2M
2
PHS
PFM Health Sciences
California
+$38.3M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$31.3M
4
VAM
Visium Asset Management
New York
+$16.6M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$21M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$20.8M
3
BM
Bridger Management
New York
-$14.5M
4
Millennium Management
Millennium Management
New York
-$13.2M
5
Invesco
Invesco
Georgia
-$11.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAA
51
Managed Account Advisors
New Jersey
$5M +$675K +180 +17%
AAP
52
Ardsley Advisory Partners
Connecticut
$5M +$4.61M +1,229 New
Marshall Wace
53
Marshall Wace
United Kingdom
$4.91M +$4.54M +1,209 New
GC
54
Guggenheim Capital
Illinois
$4.86M +$465K +124 +12%
Charles Schwab
55
Charles Schwab
California
$4.48M +$221K +59 +6%
Balyasny Asset Management
56
Balyasny Asset Management
Illinois
$4.38M +$4.04M +1,077 New
Morgan Stanley
57
Morgan Stanley
New York
$4.13M -$3.73M -995 -50%
SIM
58
Spark Investment Management
New York
$3.89M -$833K -222 -19%
U
59
UBS
Switzerland
$3.89M +$1.68M +449 +89%
CCMH
60
Cornerstone Capital Management Holdings
New York
$3.72M +$330K +88 +11%
CS
61
Credit Suisse
Switzerland
$3.56M +$855K +228 +35%
Citadel Advisors
62
Citadel Advisors
Florida
$3.56M -$21M -5,609 -87%
Royal London Asset Management
63
Royal London Asset Management
United Kingdom
$3.56M – – –
1CM
64
1492 Capital Management
Wisconsin
$3.52M +$165K +44 +5%
GL
65
GLG LLC
New York
$3.46M +$3.19M +850 New
Wells Fargo
66
Wells Fargo
California
$3.41M +$143K +38 +5%
CCI
67
Columbus Circle Investors
$3.35M +$3.09M +825 New
OAM
68
Oxford Asset Management
United Kingdom
$3.32M +$3.06M +817 New
Renaissance Technologies
69
Renaissance Technologies
New York
$3.32M +$1.76M +470 +136%
RCAMU
70
Rothschild & Co Asset Management US
Connecticut
$3.32M -$128K -34 -4%
Jane Street
71
Jane Street
New York
$3.29M +$3.03M +808 New
PAMU
72
Pictet Asset Management (UK)
United Kingdom
$3.2M -$1.39M -371 -32%
California Public Employees Retirement System
73
California Public Employees Retirement System
California
$3.19M -$56.3K -15 -2%
State of New Jersey Common Pension Fund D
74
State of New Jersey Common Pension Fund D
New Jersey
$3.05M – – –
TC
75
TFS Capital
Pennsylvania
$2.97M +$1.71M +457 +167%
1 2
3
4 5

ACOR Hedge Fund Activity: Q3 2014 in Review

174 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2014, worth a combined $1.52B — up 3.2% from $1.47B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ACOR positions and 20 closed out — a net gain of 12 holders — while 63 added to existing stakes and 58 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $42.2M. The largest seller was Citadel Advisors, cutting an estimated $21M.

  • 174 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2014, up from 162 in Q2 2014.
  • Funds reported $1.52B of Acorda Therapeutics stock for Q3 2014, up 3.2% quarter-over-quarter.
  • 32 funds opened new Acorda Therapeutics positions in Q3 2014 and 20 closed out, a net change of +12 holders.
  • The largest Acorda Therapeutics buyer in Q3 2014 was Fidelity Investments, an estimated $42.2M added.
  • The largest Acorda Therapeutics seller in Q3 2014 was Citadel Advisors, an estimated $21M sold.

Based on aggregated 13F filings for Q3 2014.